» Articles » PMID: 20709438

Cystatin C, Albuminuria, and 5-year All-cause Mortality in HIV-infected Persons

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2010 Aug 17
PMID 20709438
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Compared with controls, human immunodeficiency virus (HIV)-infected persons have a greater prevalence of kidney disease, assessed according to high cystatin C level and albuminuria, but not according to creatinine level. However, the clinical importance of increased cystatin C level and albuminuria in the HIV-infected population has not been studied.

Study Design: We conducted an observational cohort study to determine the association of kidney disease (measured according to albuminuria, cystatin C, and serum creatinine) with mortality.

Setting & Participants: 922 HIV-infected persons enrolled in the FRAM (Fat Redistribution and Metabolic Change in HIV Infection) Study.

Predictor: Serum cystatin C and serum creatinine levels were used to estimate glomerular filtration rates (eGFR(SCysC) and eGFR(SCr), respectively). Albuminuria was defined as a positive urine dipstick result (≥ 1+) or urine albumin-creatinine ratio >30 mg/g.

Outcome: 5-Year mortality.

Results: At baseline, decreased kidney function (eGFR(SCysC) <60 mL/min/1.73 m(2)) or albuminuria was present in 28% of participants. After 5 years of follow-up, mortality was 48% in those with both eGFR(SCysC) < 60 mL/min/1.73 m(2) and albuminuria, 23% in those with eGFR(SCysC) < 60 mL/min/1.73 m(2) alone, 20% in those with albuminuria alone, and 9% in those with neither condition. After multivariable adjustment for demographics, cardiovascular risk factors, HIV-related factors, and inflammatory marker levels, eGFR(SCysC) < 60 mL/min/1.73 m(2) and albuminuria were associated with a nearly 2-fold increase in mortality, whereas eGFR(SCr) < 60 mL/min/1.73 m(2) did not appear to have a substantial association with mortality. Together, eGFR(SCysC) <60 mL/min/1.73 m(2) and albuminuria accounted for 17% of the population-level attributable risk of mortality.

Limitations: Vital status was unknown in 261 participants from the original cohort.

Conclusions: Kidney disease marked by albuminuria or increased cystatin C level appears to be an important risk factor for mortality in HIV-infected individuals. A substantial proportion of this risk may be unrecognized because of the current reliance on serum creatinine to estimate kidney function in clinical practice.

Citing Articles

Brief Report: Cystatin C Provides Substantially Higher Glomerular Filtration Rate Estimates Than Creatinine in a Subset of Black People With HIV on Current Antiretroviral Regimens.

Dominguez-Dominguez L, Hamzah L, Fox J, Vincent R, Post F J Acquir Immune Defic Syndr. 2025; 98(2):171-175.

PMID: 39791983 PMC: 11708996. DOI: 10.1097/QAI.0000000000003555.


Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV.

Overton E, Kantor A, Fitch K, Mosepele M, Aberg J, Fichtenbaum C AIDS. 2024; 39(1):31-39.

PMID: 39283736 PMC: 11624062. DOI: 10.1097/QAD.0000000000004016.


High prevalence of albuminuria among adult males living with HIV in Botswana.

Mosepele M, Ponatshego P, Molebatsi K, Williams C, Mokgatlhe L, Lockman S Sci Rep. 2024; 14(1):14432.

PMID: 38910157 PMC: 11194263. DOI: 10.1038/s41598-024-65099-w.


Prevalence and risk factors for kidney disease among hospitalized PLWH in China.

Zhao N, Xiang P, Zeng Z, Liang H, Wang F, Xiao J AIDS Res Ther. 2023; 20(1):49.

PMID: 37454082 PMC: 10349439. DOI: 10.1186/s12981-023-00546-8.


Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study design.

Wester C, Shepherd B, Wudil U, Musa B, Ingles D, Prigmore H BMC Infect Dis. 2022; 22(1):591.

PMID: 35787257 PMC: 9251938. DOI: 10.1186/s12879-022-07531-y.


References
1.
Perkins B, Ficociello L, Ostrander B, Silva K, Weinberg J, Warram J . Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol. 2007; 18(4):1353-61. DOI: 10.1681/ASN.2006080872. View

2.
Knight E, Verhave J, Spiegelman D, Hillege H, de Zeeuw D, Curhan G . Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004; 65(4):1416-21. DOI: 10.1111/j.1523-1755.2004.00517.x. View

3.
Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View

4.
Ninomiya T, Perkovic V, de Galan B, Zoungas S, Pillai A, Jardine M . Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009; 20(8):1813-21. PMC: 2723977. DOI: 10.1681/ASN.2008121270. View

5.
Odden M, Scherzer R, Bacchetti P, Szczech L, Sidney S, Grunfeld C . Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. Arch Intern Med. 2007; 167(20):2213-9. PMC: 3189482. DOI: 10.1001/archinte.167.20.2213. View